Speaker: Isabel Spriet
Coordinator of the Clinical Pharmacy Services, Pharmacy Departement, UZ Leuven and associate professor in the Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven
Descriptive of the webinar:
During the last decade, the medical discipline of infectious diseases is confronted with two important challenges: the pharmaceutical industry has virtually abandoned the development of new antimicrobials and (predominantly Gram-negative) resistance is on the rise. In order to maintain availability of active antimicrobials on a population level, antimicrobials should be used carefully on an individual level. Therefore, useful antimicrobial stewardship interventions are investigated and implemented in academic research and in clinical practice. In this session, the audience will learn which antimicrobial stewardship interventions are prioritized, how these are implemented, how clinical pharmacy teams can contribute and collaborate with other caregivers involved, and what can be expected from an effectiveness point of view.
Isabel Spriet graduated as pharmacist at Ghent University, Belgium in 2002, and as a hospital pharmacist in 2003. She completed a Fellowship in Clinical Pharmacy in 2004 and a PhD on Pharmacokinetic issues in critically ill patients in 2011, both at the University of Leuven. She is coordinating clinical pharmacy services in the Pharmacy Dpt. of the University Hospitals Leuven, and is associated as professor to the Department of Pharmaceutical and Pharmacological Sciences of the University of Leuven. She is an active member of the Antimicrobial Stewardship team of the University Hospitals Leuven, and her research focuses on optimization of exposure to both antibiotics and antifungals in special patient populations, including critically ill patients. She supervises several PhD projects in this domain and published several papers on this topic.